Article Information
History
- February 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- HengSheng Fang1,
- Adam D. Wegman1,
- Kianna Ripich3,
- Heather Friberg2,
- Jeffrey R. Currier2,
- Stephen J. Thomas,
- Timothy P. Endy1 and
- Adam T. Waickman1,3,*
- 1Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse, New York, USA
- 2Viral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States
- 3Institute for Global Health and Translational Sciences, State University of New York Upstate Medical University, Syracuse, New York, USA
- ↵*Corresponding author: waickmaa{at}upstate.edu
Posted February 01, 2021.
Persistent COVID-19 symptoms minimally impact the development of SARS-CoV-2 specific cellular immunity
